CSI Market
Sign In | Register

Clovis Oncology inc (CLVS) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CLVS Annual Cash Flow →
Examining cash flow movements between Clovis Oncology inc and Sep 30 2021 reveals how Sep 30 2022 allocates cash as operating conditions evolve.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2022)
9 Months 		(Jun 30 2022) (Mar 31 2022) (Dec 31 2021) (Sep 30 2021)
Operating Activities
Income-187.52
Depreciation & amortization5.71
Amortization of Other Assets1.69
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories14.07
Research and Development in Process0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation16.92
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Amortization Of Premiums And Discounts On Available For Sale Securities-
Available For Sale Securities Gross Realized Gain Loss Net-
Noncash Acquired Inprocess Research And Development-
Increase Decrease In Prepaid And Accrued Research And Development Expenses-12.34
Increase Decrease In Allowance For Obsolete Inventories11.21
Write Off Of Deferred Debt Issuance Cost-
Write Off Of Debt Issuance Costs Related To Convertible Senior Notes Transactions-
Loss On Legal Settlement-
Income taxes1.12
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable5.47
Increase (Decrease) in Accounts Payable-8.31
Increase (Decrease) in Other Accrued Liabilities14.69
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital3.06
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-134.23
Investing Activities
Capital Expenditures-0.20
Sale of Capital Items0.00
Proceeds from Sale of Available-for-sale Securities, Debt0.00
Payments to Acquire Available-for-sale Securities, Debt0.00
Real Estate Investments0.00
Payments To Acquire Property Plant And Equipment Deposits-
Acquired In Process Research And Development Milestone Paid-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.20
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings24.16
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock29.02
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Issuance Of Convertible Preferred Stock Net Of Issuance Cost-
Proceeds From Issuance Of Convertible Promissory Notes Net Of Issuance Costs-
Payments On Other Long Term Liabilities-
Extinguishment Of Debt Amount-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities53.18
Effect of exchange rate on cash flow-3.86
Discontinued operations0.00
Free Cash Flow-134.43
Total Cash Flow-85.11
4 historic quarters locked

Sign in to unlock the full Clovis Oncology inc cash flow history.

Sign In Create Free Account

About Clovis Oncology Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001558370-22-017027

Figures are derived from filed reports and may be restated. Historical data is subject to revision.